Landmark Bio Is A Therapy Manufacturing Company That Specializes In Cell And Gene Therapiesit Was Founded Through A Collaborative Initiative Led By Harvard University President Alan Garberbringing Together Expertise From Academiaindustryand Healthcare To Tackle Manufacturing Challenges In Advanced Therapiesthe Company Focuses On Translating Innovative Research Into Effective Treatments By Emphasizing Manufacturability And Scalability From The Early Stages Of Development Landmark Bio Offers Services In Process Developmentguiding Sponsors To Design Scalablegmp Compliant Processesand Manufacturing Solutions That Include Technology Transfer And Analytical Method Developmentthe Company Collaborates With Academic Spinoutsbiotech Startupsand Hospitals To De Risk Therapy Development Through Early Stage Planningin April 2025Landmark Bio Was Acquired By Artis Biosolutionswhich Aims To Enhance Its Manufacturing Capabilities And Support The Commercialization Of Cell And Gene Therapies
No conferences found for this company.
| Company Name | Landmark Pharma |
| Country |
India
|
| Address | N/A |
| Telephone | N/A |
| N/A |
